GB0326518D0 - Anti-cancer compounds - Google Patents

Anti-cancer compounds

Info

Publication number
GB0326518D0
GB0326518D0 GBGB0326518.8A GB0326518A GB0326518D0 GB 0326518 D0 GB0326518 D0 GB 0326518D0 GB 0326518 A GB0326518 A GB 0326518A GB 0326518 D0 GB0326518 D0 GB 0326518D0
Authority
GB
United Kingdom
Prior art keywords
cancer compounds
relates
present
cancer
terpene compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0326518.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compton Developments Ltd
Original Assignee
Compton Developments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compton Developments Ltd filed Critical Compton Developments Ltd
Priority to GBGB0326518.8A priority Critical patent/GB0326518D0/en
Publication of GB0326518D0 publication Critical patent/GB0326518D0/en
Priority to AU2004290946A priority patent/AU2004290946B2/en
Priority to DE602004022578T priority patent/DE602004022578D1/de
Priority to JP2006538951A priority patent/JP2007511492A/ja
Priority to PCT/GB2004/004769 priority patent/WO2005049001A1/en
Priority to CN2004800336500A priority patent/CN1882319B/zh
Priority to CN201010205334A priority patent/CN101862365A/zh
Priority to KR1020067011566A priority patent/KR20060121177A/ko
Priority to EP04798492A priority patent/EP1682107B1/en
Priority to US10/579,135 priority patent/US20070259056A1/en
Priority to AT04798492T priority patent/ATE439126T1/de
Priority to DK04798492T priority patent/DK1682107T3/da
Priority to CA002545717A priority patent/CA2545717A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GBGB0326518.8A 2003-11-13 2003-11-13 Anti-cancer compounds Ceased GB0326518D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0326518.8A GB0326518D0 (en) 2003-11-13 2003-11-13 Anti-cancer compounds
CA002545717A CA2545717A1 (en) 2003-11-13 2004-11-12 Anti-tumour terpene compounds
CN201010205334A CN101862365A (zh) 2003-11-13 2004-11-12 抗肿瘤萜类化合物
DE602004022578T DE602004022578D1 (de) 2003-11-13 2004-11-12 Antitumorale terpen-verbindungen
JP2006538951A JP2007511492A (ja) 2003-11-13 2004-11-12 抗腫瘍テルペン化合物
PCT/GB2004/004769 WO2005049001A1 (en) 2003-11-13 2004-11-12 Anti-tumour terpene compounds
CN2004800336500A CN1882319B (zh) 2003-11-13 2004-11-12 抗肿瘤萜类化合物
AU2004290946A AU2004290946B2 (en) 2003-11-13 2004-11-12 Anti-tumour terpene compounds
KR1020067011566A KR20060121177A (ko) 2003-11-13 2004-11-12 항종양 테르펜 화합물
EP04798492A EP1682107B1 (en) 2003-11-13 2004-11-12 Anti-tumour terpene compounds
US10/579,135 US20070259056A1 (en) 2003-11-13 2004-11-12 Anti-Tumour Terpene Compounds
AT04798492T ATE439126T1 (de) 2003-11-13 2004-11-12 Antitumorale terpen-verbindungen
DK04798492T DK1682107T3 (da) 2003-11-13 2004-11-12 Anti-tumor terpenforbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0326518.8A GB0326518D0 (en) 2003-11-13 2003-11-13 Anti-cancer compounds

Publications (1)

Publication Number Publication Date
GB0326518D0 true GB0326518D0 (en) 2003-12-17

Family

ID=29726508

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0326518.8A Ceased GB0326518D0 (en) 2003-11-13 2003-11-13 Anti-cancer compounds

Country Status (12)

Country Link
US (1) US20070259056A1 (https=)
EP (1) EP1682107B1 (https=)
JP (1) JP2007511492A (https=)
KR (1) KR20060121177A (https=)
CN (2) CN1882319B (https=)
AT (1) ATE439126T1 (https=)
AU (1) AU2004290946B2 (https=)
CA (1) CA2545717A1 (https=)
DE (1) DE602004022578D1 (https=)
DK (1) DK1682107T3 (https=)
GB (1) GB0326518D0 (https=)
WO (1) WO2005049001A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101849981B (zh) * 2010-06-22 2011-11-23 南京中医药大学 一种具有抗妇科肿瘤作用的没药有效部位及其制备方法和其应用
WO2012033634A2 (en) 2010-09-09 2012-03-15 Mary Kay Inc. Topical skin care formulations comprising plant extracts
WO2018144954A1 (en) * 2017-02-03 2018-08-09 City Of Hope Silica nanoparticle with an insoluble drug
WO2020033567A1 (en) * 2018-08-07 2020-02-13 University Of Florida Research Foundation Methods and compositions for substituted arylcycloheptane analogs
CN110960518B (zh) * 2019-12-31 2022-12-20 河南大学 金丝大菊提取物在制备抗肿瘤药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190979A (en) * 1988-06-24 1993-03-02 Stephen Herman Ozonides of terpenes and their medical uses
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5602184A (en) * 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPO316796A0 (en) * 1996-10-23 1996-11-14 Hood, John James David Essential oil
US6464839B1 (en) 1997-04-14 2002-10-15 Yuan Da International Group Limited Beta-elemene, method to prepare the same and uses thereof
US6265639B1 (en) * 1998-01-22 2001-07-24 Washington State University Foundation Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use
FR2808196A1 (fr) 2000-04-27 2001-11-02 Andre Rougereau Nouveaux medicaments a base de melanges de sesquiterpenes
FR2811899B1 (fr) * 2000-07-20 2003-02-07 Anne Marie Pierrette Giraud Association d'huiles essentielles et applications therapeutiques
US6486706B2 (en) 2000-12-06 2002-11-26 Intel Corporation Domino logic with low-threshold NMOS pull-up
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
WO2002080951A1 (en) * 2001-04-06 2002-10-17 Synergistix Biotech, Inc. Herbal extracts for the treatment of cancer
GB0210152D0 (en) * 2002-05-02 2002-06-12 Compton Developments Ltd Use of plant materials
EP1587482A4 (en) * 2003-01-31 2010-08-25 Technion Res & Dev Foundation INFLAMMATORY COMPOSITIONS AND ITS USES
US20050074509A1 (en) * 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components

Also Published As

Publication number Publication date
DE602004022578D1 (de) 2009-09-24
EP1682107B1 (en) 2009-08-12
DK1682107T3 (da) 2009-12-14
AU2004290946B2 (en) 2010-04-22
KR20060121177A (ko) 2006-11-28
WO2005049001A1 (en) 2005-06-02
CN1882319A (zh) 2006-12-20
US20070259056A1 (en) 2007-11-08
CN101862365A (zh) 2010-10-20
CN1882319B (zh) 2010-08-25
JP2007511492A (ja) 2007-05-10
ATE439126T1 (de) 2009-08-15
CA2545717A1 (en) 2005-06-02
AU2004290946A1 (en) 2005-06-02
EP1682107A1 (en) 2006-07-26

Similar Documents

Publication Publication Date Title
PL365783A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
GB0215844D0 (en) Organic compounds
GB0114286D0 (en) Nucleoside Derivatives
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
WO2004112695A3 (en) Methods and compositions for delivery of catecholic butanes for treatment of obesity
MY126527A (en) Novel dihydropyrimidines
TW200508214A (en) Novel compounds
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
PL367682A1 (en) Dolastatin 10 derivatives
GB0112348D0 (en) Compounds
AU2003216109A1 (en) Therapeutic composition for treatment of cancer by arginine depletion
WO2005030794A3 (en) Hemiasterlin derivatives and uses thereof
GR1004358B (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
GB0326518D0 (en) Anti-cancer compounds
TW200504051A (en) Novel acridine derivatives and their use as medicaments
WO2005118584A3 (en) Saframycin analogs as therapeutic agents in the treatment of cancer
PL1718651T3 (pl) Pochodne 7H-pirolopirymidyny
WO2002040477A3 (en) Saframycins, analogues and uses thereof
GB0305928D0 (en) Organic compounds
WO2003020371A3 (en) Potentiator composition comprising a terpene for enhancing a therapeutical effect of antitumoral agents in the treatment of cancer
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
WO2003014128A3 (de) Tumorhemmende cerverbindungen
MXPA05006378A (es) Compuestos esteroides con actividad anti-tumoral.
NZ544481A (en) norgestrel 3e- and -3z-oxime isomers, as well as process for the synthesis of the mixture of isomers and the pure isomers
WO2006066183A3 (en) Novel saframycin analogs as therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)